Orphan receptor IL-17RD tunes IL-17A signalling and is required for neutrophilia - PubMed (original) (raw)

Orphan receptor IL-17RD tunes IL-17A signalling and is required for neutrophilia

Mark Mellett et al. Nat Commun. 2012.

Free article

Abstract

Interleukin-17A, the prototypical member of the interleukin-17 cytokine family, coordinates local tissue inflammation by recruiting neutrophils to sites of infection. Dysregulation of interleukin-17 signalling has been linked to the pathogenesis of inflammatory diseases and autoimmunity. The interleukin-17 receptor family members (A-E) have a broad range of functional effects in immune signalling yet no known role has been described for the remaining orphan receptor, interleukin-17 receptor D, in regulating interleukin-17A-induced signalling pathways. Here we demonstrate that interleukin-17 receptor D can differentially regulate the various pathways employed by interleukin-17A. Neutrophil recruitment, in response to in vivo administration of interleukin-17A, is abolished in interleukin-17 receptor D-deficient mice, correlating with reduced interleukin-17A-induced activation of p38 mitogen-activated protein kinase and expression of the neutrophil chemokine MIP-2. In contrast, interleukin-17 receptor D deficiency results in enhanced interleukin-17A-induced activation of nuclear factor-kappa B and interleukin-6 and keratinocyte chemoattractant expression. Interleukin-17 receptor D disrupts the interaction of Act1 and TRAF6 causing differential regulation of nuclear factor-kappa B and p38 mitogen-activated protein kinase signalling pathways.

PubMed Disclaimer

References

    1. J Immunol. 2000 Nov 15;165(10):5814-21 - PubMed
    1. Immunology. 2010 Mar;129(3):311-21 - PubMed
    1. Immunity. 2009 Jan 16;30(1):108-19 - PubMed
    1. J Immunol. 1999 Feb 15;162(4):2347-52 - PubMed
    1. Trends Biochem Sci. 2003 May;28(5):226-9 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources